|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.1775 SEK | -2.47% |
|
-3.27% | -1.11% |
| 08-25 | XP Chemistries AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-25 | XP Chemistries Q2 Net Sales Amounted To SEK 59,000 | RE |
| Market Cap | 55.73M 5.55M 4.93M 4.61M 4.2M 7.92M 534M 7.99M 21.6M 273M 20.85M 20.4M 876M | P/E 2024 |
-1.48x | P/E 2025 | -5.22x |
|---|---|---|---|---|---|
| Enterprise Value | 40.5M 4.04M 3.59M 3.35M 3.05M 5.75M 388M 5.81M 15.7M 198M 15.15M 14.82M 637M | EV / Sales 2024 |
43.7x | EV / Sales 2025 | 126x |
| Free-Float |
44.34% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| XPC | Delayed | |
Deutsche Boerse AG
| 86Q | Delayed | |
|
Börse Stuttgart
| 86Q | Delayed | |
|
Boerse Muenchen
| 86Q | Real-time |
| 1 day | -2.47% | ||
| 1 week | -3.27% | ||
| Current month | -2.20% | ||
| 1 month | -2.47% | ||
| 3 months | +6.93% | ||
| 6 months | -5.33% | ||
| Current year | -1.11% |
| 1 week | 0.17 |  | 0.18 |
| 1 month | 0.17 | | 0.22 |
| Current year | 0.15 | | 0.22 |
| 1 year | 0.15 | | 0.29 |
| 3 years | 0.03 | | 0.5 |
| 5 years | 0.03 | | 4.5 |
| 10 years | 0.03 | | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Nelsson
CEO | Chief Executive Officer | 43 | 2020-12-31 |
Anders Frejdh
DFI | Director of Finance/CFO | 52 | 2020-12-31 |
Shuang Zheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Armando Córdova
CHM | Chairman | 56 | 2014-12-31 |
Samson Afewerki
BRD | Director/Board Member | 41 | 2014-12-31 |
Anna Svantes
BRD | Director/Board Member | 35 | 2020-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/15/24 | Buy | Chief Executive Officer | 20,000 | 0.0136% | ||
| 4/15/24 | Buy | Chief Executive Officer | 30,000 | 0.0204% | ||
| 4/15/24 | Buy | Chief Executive Officer | 50,000 | 0.0340% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.47% | -3.27% | -28.71% | -50.69% | 5.55M | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.93% | -3.38% | +20.59% | +47.94% | 369.72B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 284K 28.29K 25.14K 23.46K 21.39K 40.33K 2.72M 40.71K 110K 1.39M 106K 104K 4.46M | 327K 32.62K 28.99K 27.05K 24.66K 46.51K 3.14M 46.94K 127K 1.6M 122K 120K 5.15M |
| Net income | -7.13M -711K -632K -589K -537K -1.01M -68.33M -1.02M -2.76M -34.93M -2.67M -2.61M -112M | -8.52M -849K -754K -704K -642K -1.21M -81.62M -1.22M -3.3M -41.73M -3.19M -3.12M -134M |
| Net Debt | -2.15M -214K -190K -177K -162K -305K -20.55M -308K -831K -10.51M -803K -785K -33.71M | -15.23M -1.52M -1.35M -1.26M -1.15M -2.16M -146M -2.18M -5.9M -74.56M -5.7M -5.57M -239M |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | SEK 0.1775 | -2.47% | 384,382 |
| 26-10-01 | SEK 0.1820 | +0.28% | 473,969 |
| 26-09-30 | SEK 0.1815 | +1.97% | 166,295 |
| 26-09-29 | SEK 0.1780 | -2.73% | 372,260 |
| 26-09-28 | SEK 0.1830 | -0.27% | 82,845 |
- Stock Market
- Stocks
- XPC Stock
Select your edition
All financial news and data tailored to specific country editions
